The CEFI Foundation, Center for the Promotion of Research, has devoted its activities and efforts for forty-two years to the promotion and defense of the protection of research and technological development, primarily from legal and economic perspectives and especially in the pharmaceutical field.
The CEFI Foundation expresses its firm opposition to the proposed amendment of Article 26.2 of the Law on the Government, relating to the public consultation procedure, as put forward through Amendment No. 76 submitted by the Socialist Parliamentary Group and the Sumar Parliamentary Group.
Proposals of the CEFI Foundation in response to the prior public consultation on the draft Royal Decree on Health Technology Assessment
CEFI’s Observations on the Communication Regarding the Criteria for Determining the Prohibition to Contract Due to Distortion of Competition by the Spanish National Commission on Markets and Competition (CNMC)
Why would compulsory licences for COVID-19 vaccines and treatments not lead to better access to innovation or benefits for patients?
CEFI Position Paper: Changes to the National Health System in Favour of Innovation, Efficiency and Patient Care
The Manufacturing Waiver for Export Purposes of the SPC vs. the Protection of Industrial Property and Biomedical Innovation
